Gold’s recovery faced stiff resistance just below the $1770 level. XAU/USD set to fall? Technicals are set to outweigh Evergrande risks, FXStreet’s Dhwani Mehta briefs.
Gold price looks to resume the downside after Monday’s rebound
“A minor improvement in the risk sentiment amid stabilizing Hong Kong equities and conciliatory comments from China Evergrande Chief caps gold’s recovery gains.”
“Fed’s tapering plan appears intact, despite the latest China worries. The risk rebound could pick up pace, extending the rebound in the Treasury yields while lifting the demand for the greenback once again. In such a case, XAU/USD will likely resume its downside.”
“The 21-Daily Moving Average (DMA) is set to pierce the 50-DMA from above. If such a move materializes, then it would confirm a bear cross, opening floors for a fresh downswing towards the multi-week troughs near $1740. The $1700 psychological magnate will be on the sellers’ radars should the monthly lows give way.”
“A sustained move above the $1767 supply zone is needed to unleash the recovery gains towards the 21 and 50-DMA confluence near $1795. Gold bulls will then aim for the horizontal 200-DMA at $1807, as the next upside target.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.